Filing Flows

Filing Flows › Companies › Astrana Health › Timeline

Astrana Health stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+3.4% to $34.50

Astrana Health (ASTH) stock rose 3% over the last 252 sessions, to $34.50. On the way it reported 5 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 4 material 8-Ks. Each is marked on the price and listed with what the stock did next.

ASTH: a year of the stock with every disclosure on itASTH: a year of the stock with every disclosure on it$24.81$34.00$43.18$52.37●2025-11-06 · Earnings: beat the EPS estimate by 10.6%●2026-03-02 · Earnings: beat the EPS estimate by 28.6%●2026-05-07 · Earnings: beat the EPS estimate by 13.8%◆2026-05-12 · Directors and officers: departures, appointments, pay◆2026-06-10 · Directors and officers: departures, appointments, pay◆2026-07-01 · Directors and officers: departures, appointments, pay●2026-08-06 · Earnings: beat the EPS estimate by 9.6%◆2026-09-23 · Material cybersecurity incident●2026-11-05 · Earnings: missed the EPS estimate by -19.0%●Earnings report◆8-K event2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 5, 2026EarningsEarnings: missed the EPS estimate by -19.0%−1.7% (+2.8% vs SPY)——
Sep 23, 20268-KMaterial cybersecurity incident−2.2% (−1.5% vs SPY)+1.0% (+2.1% vs SPY)+6.2% (+6.2% vs SPY)
Aug 6, 2026EarningsEarnings: beat the EPS estimate by 9.6%−4.9% (−4.7% vs SPY)−0.1% (−0.5% vs SPY)+5.4% (+5.0% vs SPY)
Jul 1, 20268-KDirectors and officers: departures, appointments, pay−1.3% (−1.2% vs SPY)−6.2% (−7.0% vs SPY)−33.7% (−33.9% vs SPY)
Jun 10, 20268-KDirectors and officers: departures, appointments, pay+2.8% (+1.2% vs SPY)−1.5% (−3.6% vs SPY)+20.7% (+17.3% vs SPY)
May 12, 20268-KDirectors and officers: departures, appointments, pay+2.7% (+2.8% vs SPY)+2.6% (+2.7% vs SPY)+2.0% (+3.9% vs SPY)
May 7, 2026EarningsEarnings: beat the EPS estimate by 13.8%+2.3% (+2.6% vs SPY)+12.0% (+10.9% vs SPY)+7.5% (+7.0% vs SPY)
Mar 2, 2026EarningsEarnings: beat the EPS estimate by 28.6%+25.8% (+25.8% vs SPY)+20.3% (+22.3% vs SPY)+18.0% (+26.0% vs SPY)
Nov 6, 2025EarningsEarnings: beat the EPS estimate by 10.6%+0.4% (+1.4% vs SPY)−34.4% (−35.3% vs SPY)−40.9% (−42.1% vs SPY)

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.05 Material cybersecurity incident42−0.6%33%−0.2%±1.6%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Astrana Health: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.